» Articles » PMID: 34532064

Using Host Genetics to Infer the Global Spread and Evolutionary History of HCV Subtype 3a

Overview
Journal Virus Evol
Date 2021 Sep 17
PMID 34532064
Authors
Affiliations
Soon will be listed here.
Abstract

Studies have shown that hepatitis C virus subtype 3a (HCV-3a) is likely to have been circulating in South Asia before its global spread. However, the time and route of this dissemination remain unclear. For the first time, we generated host and virus genome-wide data for more than 500 patients infected with HCV-3a from the UK, North America, Australia, and New Zealand. We used the host genomic data to infer the ancestry of the patients and used this information to investigate the epidemic history of HCV-3a. We observed that viruses from hosts of South Asian ancestry clustered together near the root of the tree, irrespective of the sampling country, and that they were more diverse than viruses from other host ancestries. We hypothesized that South Asian hosts are more likely to have been infected in South Asia and used the inferred host ancestries to distinguish between the location where the infection was acquired and where the sample was taken. Next, we inferred that three independent transmission events resulted in the spread of the virus from South Asia to the UK, North America, and Oceania. This initial spread happened during or soon after the end of World War II. This was subsequently followed by many independent transmissions between the UK, North America, and Oceania. Using both host and virus genomic information can be highly informative in studying the virus epidemic history, especially in the context of chronic infections where migration histories need to be accounted for.

Citing Articles

Retreatment of patients with chronic hepatitis C, subtype 3a, and cirrhosis, who previously failed a regimen containing second-generation NS5A inhibitors with sofosbuvir + glecaprevir/pibrentasvir and ribavirin for 16-24 weeks.

Fedorchenko S, Klimenko Z, Martynovich T, Solianyk I, Suprunenko T J Virol. 2025; 99(2):e0184324.

PMID: 39840947 PMC: 11852967. DOI: 10.1128/jvi.01843-24.

References
1.
El-Serag H, Kanwal F, Richardson P, Kramer J . Risk of hepatocellular carcinoma after sustained virological response in Veterans with hepatitis C virus infection. Hepatology. 2016; 64(1):130-7. PMC: 4917456. DOI: 10.1002/hep.28535. View

2.
Ansari M, Pedergnana V, Ip C, Magri A, von Delft A, Bonsall D . Genome-to-genome analysis highlights the effect of the human innate and adaptive immune systems on the hepatitis C virus. Nat Genet. 2017; 49(5):666-673. PMC: 5873514. DOI: 10.1038/ng.3835. View

3.
Xie W, Lewis P, Fan Y, Kuo L, Chen M . Improving marginal likelihood estimation for Bayesian phylogenetic model selection. Syst Biol. 2010; 60(2):150-60. PMC: 3038348. DOI: 10.1093/sysbio/syq085. View

4.
Simmonds P, Bukh J, Combet C, Deleage G, Enomoto N, Feinstone S . Consensus proposals for a unified system of nomenclature of hepatitis C virus genotypes. Hepatology. 2005; 42(4):962-73. DOI: 10.1002/hep.20819. View

5.
Kanwal F, Kramer J, Ilyas J, Duan Z, El-Serag H . HCV genotype 3 is associated with an increased risk of cirrhosis and hepatocellular cancer in a national sample of U.S. Veterans with HCV. Hepatology. 2014; 60(1):98-105. PMC: 4689301. DOI: 10.1002/hep.27095. View